A new wave of cancer treatments is looking promising for the future of oncologic care. The ovarian cancer drug RC88, which is made by the Chinese biopharmaceutical company RemeGen, received FDA ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A second dendritic cell vaccine has received fast track designation from the Food and Drug Administration. The Food and Drug Administration (FDA) has granted a fast track designation to a dendritic ...

SAN DIEGO, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today announced that ...

A discovery into the cause of one of the deadliest cancers has been uncovered, which could hold the key to new treatments, scientists said. The American Cancer Society estimates that 21,000 women will ...

JSKN003 has shown a 63% objective response rate and 7.7 months median progression-free survival in PROC patients, with higher efficacy in HER2-positive subgroups. The FDA's fast track designation ...

FAST-Forward is a major international clinical trial investigating the best way to deliver radiotherapy for early breast cancer. It compared the standard three-week schedule (40Gy in 15 treatments) ...

BriaCell Therapeutics aims to create cancer immunotherapy by irradiating and engineering existing cancer cells. Lead candidate Bria-IMT for breast cancer showed good tolerability and efficacy in 46 ...

The ability of mutations to cause cancer depends on how fast they force cells to divide, Sinai Health researchers have found. The research findings, published in Nature, have implications for ...